Rob Intile, Jr. is counsel in the firm’s Business Law department and a member of its Technology group. He concentrates his practice on representing emerging technology and life sciences companies from startup to IPO. Rob advises companies in early-stage formation and strategy, venture capital financings, corporate governance, mergers and acquisitions, and public offerings of securities.
Representative Matters
- Alpha Wave in the $100 million Series C financing of Biolinq
- B Capital in the $21 million Series B financing of Sift
- Optum Ventures in the $25 million financing of Humata Health
- BrightMind Partners in the $17 million financing of Vijil
- Flare Capital in the $25 million financing of Knownwell
- Ethyca in its $10 million financing
- IDRx in its $120 million Series B financing
- Truveris in its $15 million Series E financing
- Cardflight in its Growth investment from WestView Capital
- Plug Power in its $200 million public offering
- Rezonate in its sale to Silverfort
- Marea Therapeutics in its combined $190 million Series A and B financings
- Vatn Systems in its $13 million Seed financing
Areas of Practice
Professional Activities
Rob is a member of the Massachusetts LGBTQ Bar Association and the Boston Bar Association.
Professional Experience
Prior to attending law school, Rob was a theatrical producer in New York, where he worked with new musical theatre writers and leading non-profit institutional theatre companies.
Credentials
Education
JD2015
Boston University School of Law
BA2007
Albright College
Admissions
Bars
- Massachusetts